Elevai Labs, Common Stock Probability of Future Stock Price Finishing Over 2.49
| ELAB Stock | 2.49 0.08 3.11% |
Elevai |
Elevai Labs, Target Price Odds to finish over 2.49
The tendency of Elevai Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.49 | 90 days | 2.49 | about 79.75 |
Based on a normal probability distribution, the odds of Elevai Labs, to move above the current price in 90 days from now is about 79.75 (This Elevai Labs, Common probability density function shows the probability of Elevai Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Elevai Labs, Common has a beta of -2.31 suggesting as returns on its benchmark rise, returns on holding Elevai Labs, Common are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Elevai Labs, is expected to outperform its benchmark. Additionally Elevai Labs, Common has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Elevai Labs, Price Density |
| Price |
Predictive Modules for Elevai Labs,
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Elevai Labs, Common. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Elevai Labs, Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Elevai Labs, is not an exception. The market had few large corrections towards the Elevai Labs,'s value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Elevai Labs, Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Elevai Labs, within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -2.93 | |
β | Beta against Dow Jones | -2.31 | |
σ | Overall volatility | 18.91 | |
Ir | Information ratio | -0.21 |
Elevai Labs, Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Elevai Labs, for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Elevai Labs, Common can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Elevai Labs, Common generated a negative expected return over the last 90 days | |
| Elevai Labs, Common has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 1.71 M. Net Loss for the year was (4.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Elevai Labs, generates negative cash flow from operations | |
| Elevai Labs, Common has a frail financial position based on the latest SEC disclosures | |
| About 73.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Elevai Biosciences, a Subsidiary of Elevai Labs Inc. ... |
Elevai Labs, Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Elevai Stock often depends not only on the future outlook of the current and potential Elevai Labs,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Elevai Labs,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.7 M | |
| Cash And Short Term Investments | 3.3 M |
Elevai Labs, Technical Analysis
Elevai Labs,'s future price can be derived by breaking down and analyzing its technical indicators over time. Elevai Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Elevai Labs, Common. In general, you should focus on analyzing Elevai Stock price patterns and their correlations with different microeconomic environments and drivers.
Elevai Labs, Predictive Forecast Models
Elevai Labs,'s time-series forecasting models is one of many Elevai Labs,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Elevai Labs,'s historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Elevai Labs, Common
Checking the ongoing alerts about Elevai Labs, for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Elevai Labs, Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Elevai Labs, Common generated a negative expected return over the last 90 days | |
| Elevai Labs, Common has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 1.71 M. Net Loss for the year was (4.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Elevai Labs, generates negative cash flow from operations | |
| Elevai Labs, Common has a frail financial position based on the latest SEC disclosures | |
| About 73.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Elevai Biosciences, a Subsidiary of Elevai Labs Inc. ... |
Check out Elevai Labs, Backtesting, Elevai Labs, Valuation, Elevai Labs, Correlation, Elevai Labs, Hype Analysis, Elevai Labs, Volatility, Elevai Labs, History as well as Elevai Labs, Performance. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs,. If investors know Elevai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevai Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (88.92) | Revenue Per Share 0.168 | Quarterly Revenue Growth 0.913 | Return On Assets (0.89) | Return On Equity (3.51) |
The market value of Elevai Labs, Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs,'s value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs,'s market value can be influenced by many factors that don't directly affect Elevai Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevai Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevai Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevai Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.